Good morning.

The Fast FiveTrump backtracks on 20% Hormuz fee, IBM stock's worst day in 50+ years, Warsh vows to 'double down' on Fed’s inflation target, NY enacts data center moratorium, and Buffett excludes Gates Foundation from annual donations of Berkshire stock…

📌 Forget SpaceX. Elon's next big bet is a radical "light-speed" device that's turning AI into "Accelerated AI" — abd the mainstream hasn’t caught on yet. Go here to learn how to get ahead of Elon’s next play →
(from Inflection Point)

  • Today:
    Producer Price Index, 8:30A
    Fed Beige Book 2:00P

  • Tomorrow:
    Retail Sales, 8:30A
    Unemployment Claims, 8:30A

Your 5-minute briefing for Wednesday, July 15:

BEFORE THE OPEN

As of market close 7/14/2026.

Pre-Market:

Market Wrap:

  • Tue: Dow +10 (+0.02%), S&P +0.38%, Nasdaq +0.9%

  • Cooler-than-expected inflation helped lift stocks

  • Chipmakers rebounded, driving the Nasdaq higher

  • June CPI fell 0.4%, easing rate-hike expectations

  • IBM plunged 25% after warning of weaker profits

  • Big banks rallied following strong quarterly results

  • Focus turns to CPI and Fed Chair Warsh’s testimony

EARNINGS

Here’s what we’re watching today:

It's smaller than a fingertip. It's made of glass. And it's about to reshape AI from the ground up.

Jensen Huang, Nvidia's CEO, says this device is shattering the limitations of AI and without it, AI can't scale.

Google Ventures says it's the future of AI compute.

And Sequoia Capital – the firm that backed Anthropic and OpenAI – calls it a "holy grail".

Yet most Americans have never heard of it…

Wall Street insider Jason Bodner – the same man who called Nvidia at $4.50 – says this critical "light-speed" device could be bigger for AI than GPUs… and it's about to launch a whole new wave of AI winners.

And to prove it, he's giving away his #1 stock involved with it – for no cost.

- a sponsored message from Inflection Point -

HEADLINES

IBM stock collapsed 25% after the company preannounced its Q2 earnings results.

Kevin Warsh, in his first testimony to Congress as chairman of the Federal Reserve, did not shed light on whether he supported higher interest rates to tame price pressures.

  • Stocks rise after cooler-than-expected CPI report (more)

  • Trump backtracks on 20% Hormuz 'Guardian' fee (more)

  • Tariff refunds weigh on federal budget (more)

  • US consumer inflation moderates; upside risks remain amid Iran conflict (more)

    • Top Fed officials embrace cooler inflation reading, clamor for more (more)

  • NY enacts data center moratorium (more)

  • Oil rises after US-Iran hostilities flare again with strikes on energy targets (more)

  • Dollar struggles as softer inflation dims Fed hike bets (more)

  • JPMorgan posts highest quarterly profit ever by a US bank as dealmaking, stock trading surge (more)

  • Wells Fargo profit beats estimates on wealth, investment banking (more)

  • Citi shares fall as investor worry over expenses overshadows profit beat (more)

  • Wall Street banks see AI 'super cycle' set to boost deals, financing (more)

  • OpenAI’s first device will be movable, screenless speaker AI companion (more)

  • Buffett excludes Gates Foundation from annual donations of Berkshire stock (more)

  • Boomer wealth transfer set to favor America’s richest families (more)

DEALFLOW

M+A | Investments

  • Vault and Genesis agree to merge and create $8.71B Australian gold producer

  • LNG Canada, Indigenous Groups agree $711M equity option

  • Thomson Reuters to sell stake in legal, tax business to KKR

  • Nebius to sell $1 billion in AI capacity to Reflection

  • Heavy metal icon Iron Maiden sells stake in music rights to Pophouse

  • Prosperity Partners receives investment from Lightyear Capital

  • TransPak receives investment from Odyssey Investment Partners

VC

  • Chai Discovery, an AI model to discover new molecules, raised $400M in Series C funding

  • TerraFirma, a vertically integrated construction company, raised $100M in Series A funding

  • Singularity, a defense tech company, raised $80M in Series A funding

  • State Affairs, an AI-powered platform for policy and regulatory markets, raised $70M in funding

  • Drug Farm, a biotech company developing novel drug targets, raised $55M in the first close of its Series D funding

  • Quadric, a licensor of programmable general-purpose AI inference processor IP, extended its Series C to $46M

  • TYLsemi, a chiplet platform company, raised $43M in funding

  • Feathery, an AI operating and decisioning system for financial services, closed a $30M Series A financing

  • Hadrius, an agentic compliance infrastructure platform for financial services firms, raised $27M in combined Seed and Series A funding

  • 410 Medical, a medical device company developing technology for emergency and critical care, raised $12M in funding

  • Pact Labs, the development and infrastructure-building arm of PACT, raised $7M in Series A funding

  • Linker Finance, a modular platform built for community banks, raised $5M in Seed funding

  • Corner Health, empowers Nurse Practitioners to start and scale their own primary care practices, closed Series A financing in undisclosed amount

  • Sabanto, an autonomous retrofit technology for agriculture, closed a Series B financing in undisclosed amount

CRYPTO

  • Bitcoin ticks up to $64K following largest inflation slowdown in six years (more)

  • Some Senate Democrats come out against Clarity Act, calling it a 'corrupt' bill (more)

  • US government moves $288M in seized crypto to Coinbase Prime (more)

  • Binance bets on becoming a crypto 'super app' as stablecoins reshape growth (more)

BULLISH BITES

💰 How Warren Buffett plans to dispose of his $140B Berkshire stake.

💼 AI is the business-model shock law firms need.

✈️ Caviar on the ground, coach on the plane: A $1,300 detour around airport chaos.

🚒 He turned this Manhattan firehouse into a modern live-work space.

DAILY SHARES

*sponsored message

Disclaimer: Market Briefing© is a news publisher. All statements and expressions herein are the sole opinions of the authors or paid advertisers. The information, tools, and material presented are provided for informational purposes only, are not financial advice, and are not to be used or considered as an offer to buy or sell securities; and the publisher does not guarantee their accuracy or reliability. Please conduct your own research and consult an independent financial adviser before making any investments. Neither the publisher nor any of its affiliates accepts any liability whatsoever for any direct or consequential loss howsoever arising, directly or indirectly, from any use of the information contained herein. Assets mentioned may be owned by members of the Market Briefing team.

Reply

Avatar

or to participate

Keep Reading